Thermo Fisher Scientific Inc. ( TMO) - Key Metrics
TMO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | $32.80 | $4.65 | $6.89 | $5.71 |
| 2026Q2 | $32.33 | $4.68 | $5.73 | $4.51 |
| 2026Q1 | $29.58 | $4.44 | $3.20 | $2.19 |
| 2025Q4 | $32.49 | $5.25 | $9.19 | $7.96 |
| 2025Q3 | $29.42 | $4.28 | $5.92 | $4.85 |
TMO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | 10.11% | 36.29 |
| 2026Q2 | 10.08% | 27.41 |
| 2026Q1 | 9.81% | 26.65 |
| 2025Q4 | 8.20% | 27.75 |
| 2025Q3 | 10.09% | 27.12 |
TMO Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q3 | 0.85% | 0.07% |
| 2026Q2 | 0.88% | 0.09% |
| 2026Q1 | 0.46% | 0.09% |
| 2025Q4 | 1.37% | 0.07% |
| 2025Q3 | 1.05% | 0.09% |
TMO
List: Challengers
Price: $707.07
Dividend Yield: 0.06%
Forward Dividend Yield: 0.27%
Payout Ratio: 9.69%
Dividend Per Share: 1.88 USD
Earnings Per Share: 18.96 USD
P/E Ratio: 36.12
Exchange: NYQ
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 1.2 million
Ebitda: 1.6 billionMarket Capitalization: 253.2 billion
Average Dividend Frequency: 4
Years Paying Dividends: 15
DGR3: 13.17%
DGR5: 14.63%
DGR10: 11.01%